Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. | The announcement follows a five-year, $50 billion ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.

Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands ...

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding several hundred jobs.

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

The investment, which is expected to be complete by 2030, will boost U.S. production of Roche’s continuous glucose monitoring ...

The move is part of Roche’s previously announced plan to invest $50 billion in pharmaceuticals and diagnostics over the next ...

Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.